← Open Payments lookup

SARA REISCHMAN: Open Payments

NPI 1861086803 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,017 in 230 payments from 23 companies in 2025. Trend: 2023 $1,720 · 2024 $3,813 · 2025 $6,017

Food & beverage: $6,017
CompanyPaymentsAmount
ABBVIE INC.52$1,130
NeurAxis, Inc.1$940
Janssen Biotech, Inc.31$703
Takeda Pharmaceuticals U.S.A., Inc.29$542
Madrigal Pharmaceuticals8$463
Salix Pharmaceuticals, a division of Bausch Health US, LLC21$407
Lilly USA, LLC14$294
Regeneron Healthcare Solutions, Inc.10$268
Ardelyx, Inc.13$259
GENZYME CORPORATION4$176

Products named: TREMFYA, RINVOQ, ENTYVIO, REZDIFFRA, DUPIXENT, XIFAXAN, OMVOH, IBSRELA.

Industry payments across IN — which companies pay providers there.